A year in review: our 2021 research funding update
Despite a challenging year caused by COVID-19, Cure Parkinson's has not been deterred in its efforts to identify and progress novel therapies to slow, stop and reverse Parkinson's in 2021.
Learn more
New clinical trials targeting the LRRK2 gene
LRRK2 is a protein that becomes hyperactive in some people with Parkinson’s, and this increased level of activity is believed to be involved in the progression of their Parkinson’s. Now, two biotech companies have announced plans for two new clinical trials to test their ‘LRRK2…
Paul Mayhew-Archer and friends present his poem ‘When Santa got Parkinson’s’
Cure Parkinson’s patron and TV comedy writer Paul Mayhew-Archer has written a wonderful poem as part of our Christmas Appeal, based on the notion that Father Christmas has Parkinson’s.
2021 Grouse & Grape Luncheon raises over £14k for Parkinson’s research
On Tuesday 7 December, over 90 guests attended the historic Cavalry and Guards Club on London’s Piccadilly for the annual Grouse & Grape Luncheon, raising over xx for Parkinson’s research.
Tackling toxic alpha-synuclein
Three major lines of clinical investigation are currently underway to determine if stopping the clustering of alpha-synuclein in Parkinson’s can help to slow down the progression of the disease.
Sisters fundraise and raise awareness for Cure Parkinson’s
Sisters Susanna and Eliza Kidd had a super summer of fundraising for Cure Parkinson’s!